SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 27.42 |
Enterprise Value ($M) | 14.94 |
Book Value ($M) | 131.46 |
Book Value / Share | 3.11 |
Price / Book | 0.21 |
NCAV ($M) | 91.84 |
NCAV / Share | 2.17 |
Price / NCAV | 0.30 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.85 |
Return on Assets (ROA) | -0.51 |
Return on Equity (ROE) | -0.60 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 5.30 |
Current Ratio | 5.30 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 135.90 |
Assets | 175.51 |
Liabilities | 44.06 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 7.00 |
Operating Income | -139.71 |
Net Income | -127.17 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -102.89 |
Cash from Investing | 90.19 |
Cash from Financing | -0.12 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Vaddi Krishna | 9.50 | 11.84 | |
13G/A | Flynn James E | 0.00 | -100.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
84,410 | 180,518 | 46.76 | |
88,484 | 275,255 | 32.15 | |
38,049 | 178,658 | 21.30 | |
31,033 | 139,692 | 22.22 | |
(click for more detail) |
Similar Companies | |
---|---|
PLRX – Pliant Therapeutics, Inc. | PMVP – PMV Pharmaceuticals, Inc. |
PRAX – Praxis Precision Medicines, Inc. | PRTA – Prothena Corporation plc |
PTCT – PTC Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io